IBERE PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IBERE PHARMACEUTICALS *W EXP 03/01/202, CUSIP G46843119.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IBERE PHARMACEUTICALS *W EXP 03/01/202, CUSIP G46843119.